BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23432920)

  • 21. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Glutamine-Glutamate/GABA cycle and potential target GLUD2 in alleviation of rheumatoid arthritis by Tripterygium hypoglaucum (levl.) Hutch based on metabolomics and molecular pharmacology.
    Long C; Yang Y; Wang Y; Zhang X; Zhang L; Huang S; Yang D; Qiao X; Yang Y; Guo Y
    J Ethnopharmacol; 2021 Dec; 281():114561. PubMed ID: 34454056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of Tripterygium hypoglaucum Hutch on mouse's splenic lymphocyte activation in vitro].
    Xu Y; Zheng YT; He L; Wan P; Nong X
    Zhong Yao Cai; 2008 Apr; 31(4):557-61. PubMed ID: 18661830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
    Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
    Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
    Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
    Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
    Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Tripterygium hypoglaucum Hutch in adults with chronic urticaria.
    Zhong J; Xian D; Xu Y; Liu J
    J Altern Complement Med; 2011 May; 17(5):459-64. PubMed ID: 21568746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of paternal veto cells in preventing graft-versus-host disease after HLA-haploidentical stem cell transplantation in mice].
    Wang SB; Guo KY; Hu DM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):79-81. PubMed ID: 18227034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of cyclosporine initiation time on the outcome of matched allogeneic stem-cell transplantation following fludarabine-based conditioning.
    Kedmi M; Dray L; Grisariu S; Resnick IB; Stepensky P; Aker M; Or R; Shapira MY
    Transpl Int; 2012 Dec; 25(12):1241-7. PubMed ID: 22974004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the Nuclear Erythroid 2-Related Factor 2 Antioxidant Responsive Element (Nrf2-ARE) Signaling Pathway Alleviates Acute Graft-Versus-Host Disease by Reducing Oxidative Stress and Inhibiting Infiltration of Inflammatory Cells in an Allogeneic Stem Cell Transplantation Mouse Model.
    Yi T; Li X; Wang E; Zhang Y; Fu Y; Li J; Jiang T
    Med Sci Monit; 2018 Aug; 24():5973-5979. PubMed ID: 30148822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kinetic patterns of cytokine expressions in H-2 haploidentical nonmyeloablative bone marrow transplantation in mice].
    Li X; Sun WJ; Yuan Y; Mao N; Ai HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):687-91. PubMed ID: 16129062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Induction of non-disjunction of chromosome 8 by Tripterygium hypoglaucum (Lévl.) Hutch in mouse sperm].
    Wang XY; Ding YR; Wang X
    Yi Chuan Xue Bao; 2002; 29(3):217-20. PubMed ID: 12182074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.
    Liu D; Yan C; Xu L; Wang Y; Han W; Zhang X; Liu K; Huang X
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1567-75. PubMed ID: 20546909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment.
    Shang T; Guo Y; Li XR; Zhou Z; Qi Y; Salahdiin K; Shen R; He S; Wang M; Shi ZX; Zhao X; Yang J; Fan G; Wang Y; Gao X; Zhu Y; Feng Y
    Biomed Pharmacother; 2022 Apr; 148():112675. PubMed ID: 35183993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice].
    Wang SB; Guo KY; Hu DM; Yin B
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):810-3. PubMed ID: 16793606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutamine protects mice from acute graft-versus-host disease (aGVHD).
    Song EK; Yim JM; Yim JY; Song MY; Rho HW; Yim SK; Han YH; Jeon SY; Kim HS; Yhim HY; Lee NR; Kwak JY; Sohn MH; Park HS; Jang KY; Yim CY
    Biochem Biophys Res Commun; 2013 May; 435(1):94-9. PubMed ID: 23624505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Third-party tolerogenic dendritic cells reduce allo-reactivity in vitro and ameliorate the severity of acute graft-versus-host disease in allo-bone marrow transplantation.
    Yang J; Li R; Ren Y; Yang Y; Xie R; Fan H
    Scand J Immunol; 2013 Dec; 78(6):486-96. PubMed ID: 24283771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.